Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05500118|
Recruitment Status : Recruiting
First Posted : August 12, 2022
Last Update Posted : August 12, 2022
|Condition or disease||Intervention/treatment|
|Leiomyoma, Uterine High-Intensity Focused Ultrasound Ablation Patients Decision Aids||Other: Patients Decision Aids|
|Study Type :||Observational|
|Estimated Enrollment :||120 participants|
|Official Title:||Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU|
|Estimated Study Start Date :||August 31, 2022|
|Estimated Primary Completion Date :||August 31, 2024|
|Estimated Study Completion Date :||August 31, 2027|
communication without PADs
We use traditional communication ways to discuss the conditions with patients.
communication with PADs
The committee, composed of designers, doctors, nurses and patients, bases on guidelines and evidence-based medicine to make a tool. And we use this tool to discuss the conditions with patients.
Other: Patients Decision Aids
Patient Decision Aids (PDAs) are an important way to facilitate making decision by patients, helping patients make specific and prudent choices by providing information about treatment options and corresponding outcomes, including benefits and risks, related to their health status. The purpose of PDAs is to encourage patients to participate in decision-making. It makes it easier for patients and doctors to discuss treatment options. It effectively promotes communication between patients and doctors. It can help patients combine their own needs and professional advice to make better, more individualized diagnosis and treatment options.
- Patient satisfaction after using PDAs [ Time Frame: 6-12 months ]The patients in PDAs will undertake the treatment by PDAs. And we will collect the satisfaction after 12 months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05500118
|Contact: Yu Dai, Associate Professorfirstname.lastname@example.org|
|Shenzhen Maternal and Child Health Hospital||Recruiting|
|Shenzhen, Guangdong, China, 518000|
|Contact: Ping Jin, Professor 13925206896 email@example.com|